171 related articles for article (PubMed ID: 38113227)
21. The effects of hormone replacement therapy on antithrombin III and protein C levels in menopausal women.
Lacroix KA; Bean C; Reilly R; Curran-Celentano J
Clin Lab Sci; 1997; 10(3):145-8. PubMed ID: 10167774
[TBL] [Abstract][Full Text] [Related]
22. Risk of endometrial cancer following estrogen replacement with and without progestins.
Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I
J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer risk association with postmenopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS; Kim T; Cho H; Gwak G
Eur J Endocrinol; 2024 Jan; 190(1):1-11. PubMed ID: 38128117
[TBL] [Abstract][Full Text] [Related]
24. Endometrial cancer and menopausal hormone therapy in the National Institutes of Health-AARP Diet and Health Study cohort.
Lacey JV; Leitzmann MF; Chang SC; Mouw T; Hollenbeck AR; Schatzkin A; Brinton LA
Cancer; 2007 Apr; 109(7):1303-11. PubMed ID: 17315161
[TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone replacement therapy and risk of acute pancreatitis: a population-based case-control study.
Tetsche MS; Jacobsen J; Nørgaard M; Baron JA; Sørensen HT
Am J Gastroenterol; 2007 Feb; 102(2):275-8. PubMed ID: 17311649
[TBL] [Abstract][Full Text] [Related]
26. Menopausal estrogen and estrogen-progestin replacement therapy and risk of breast cancer (United States).
Schairer C; Byrne C; Keyl PM; Brinton LA; Sturgeon SR; Hoover RN
Cancer Causes Control; 1994 Nov; 5(6):491-500. PubMed ID: 7827235
[TBL] [Abstract][Full Text] [Related]
27. Reproductive factors and exogenous hormone use in relation to risk of glioma and meningioma in a large European cohort study.
Michaud DS; Gallo V; Schlehofer B; Tjønneland A; Olsen A; Overvad K; Dahm CC; Kaaks R; Lukanova A; Boeing H; Schütze M; Trichopoulou A; Bamia C; Kyrozis A; Sacerdote C; Agnoli C; Palli D; Tumino R; Mattiello A; Bueno-de-Mesquita HB; Ros MM; Peeters PH; van Gils CH; Lund E; Bakken K; Gram IT; Barricarte A; Navarro C; Dorronsoro M; Sánchez MJ; Rodríguez L; Duell EJ; Hallmans G; Melin BS; Manjer J; Borgquist S; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Romieu I; Rinaldi S; Vineis P; Riboli E
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2562-9. PubMed ID: 20802020
[TBL] [Abstract][Full Text] [Related]
28. Race, Menopausal Hormone Therapy, and Invasive Breast Cancer in the Carolina Breast Cancer Study.
DeBono NL; Robinson WR; Lund JL; Tse CK; Moorman PG; Olshan AF; Troester MA
J Womens Health (Larchmt); 2018 Mar; 27(3):377-386. PubMed ID: 28570827
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal estrogen and progestin use in relation to breast cancer risk.
Newcomb PA; Titus-Ernstoff L; Egan KM; Trentham-Dietz A; Baron JA; Storer BE; Willett WC; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 2002 Jul; 11(7):593-600. PubMed ID: 12101105
[TBL] [Abstract][Full Text] [Related]
30. Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe.
Stahlberg C; Pedersen AT; Lynge E; Andersen ZJ; Keiding N; Hundrup YA; Obel EB; Ottesen B
Int J Cancer; 2004 May; 109(5):721-7. PubMed ID: 14999781
[TBL] [Abstract][Full Text] [Related]
31. Occupational exposure to pesticides and central nervous system tumors: results from the CERENAT case-control study.
Baldi I; De Graaf L; Bouvier G; Gruber A; Loiseau H; Meryet-Figuiere M; Rousseau S; Fabbro-Peray P; Lebailly P
Cancer Causes Control; 2021 Jul; 32(7):773-782. PubMed ID: 33876308
[TBL] [Abstract][Full Text] [Related]
32. Long-term postmenopausal hormone therapy and endometrial cancer.
Razavi P; Pike MC; Horn-Ross PL; Templeman C; Bernstein L; Ursin G
Cancer Epidemiol Biomarkers Prev; 2010 Feb; 19(2):475-83. PubMed ID: 20086105
[TBL] [Abstract][Full Text] [Related]
33. Endometrial cancer risk with menopausal hormone therapy: Health Insurance Database in South Korea-based cohort study.
Yuk JS
Int J Gynaecol Obstet; 2023 Aug; 162(2):502-513. PubMed ID: 36964935
[TBL] [Abstract][Full Text] [Related]
34. Hormone therapy and risk of ovarian cancer in postmenopausal women: a systematic review and meta-analysis.
Shi LF; Wu Y; Li CY
Menopause; 2016 Apr; 23(4):417-24. PubMed ID: 26506499
[TBL] [Abstract][Full Text] [Related]
35. Exogenous Hormone Use and Endometrial Cancer in U.S. Black Women.
Sponholtz TR; Palmer JR; Rosenberg LA; Hatch EE; Adams-Campbell LL; Wise LA
Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):558-565. PubMed ID: 29475971
[No Abstract] [Full Text] [Related]
36. Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?
Fournier A; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F
J Clin Oncol; 2009 Nov; 27(31):5138-43. PubMed ID: 19752341
[TBL] [Abstract][Full Text] [Related]
37. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
38. Reproductive factors, menopausal hormone therapies and primary liver cancer risk: a systematic review and dose-response meta-analysis of observational studies.
Zhong GC; Liu Y; Chen N; Hao FB; Wang K; Cheng JH; Gong JP; Ding X
Hum Reprod Update; 2016 Dec; 23(1):126-138. PubMed ID: 27655589
[TBL] [Abstract][Full Text] [Related]
39. Ovarian cancer and menopausal hormone therapy in the NIH-AARP diet and health study.
Trabert B; Wentzensen N; Yang HP; Sherman ME; Hollenbeck A; Danforth KN; Park Y; Brinton LA
Br J Cancer; 2012 Sep; 107(7):1181-7. PubMed ID: 22929888
[TBL] [Abstract][Full Text] [Related]
40. Menopausal hormone therapy and dementia: nationwide, nested case-control study.
Pourhadi N; Mørch LS; Holm EA; Torp-Pedersen C; Meaidi A
BMJ; 2023 Jun; 381():e072770. PubMed ID: 37380194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]